RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
1-Year Return
12.81%
This Quarter Return
-2.03%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$1.01B
AUM Growth
-$490M
(-33%)
Cap. Flow
-$433M
Cap. Flow
% of AUM
-42.73%
Top 10 Holdings %
Top 10 Hldgs %
28.64%
Holding
97
New
5
Increased
11
Reduced
69
Closed
8
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$19.9M |
| 2 |
BioNTech
BNTX
|
$14.5M |
| 3 |
Align Technology
ALGN
|
$6.54M |
| 4 |
Cytokinetics
CYTK
|
$5.34M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
$5.3M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$31.6M |
| 2 |
Elevance Health
ELV
|
$25.4M |
| 3 |
McKesson
MCK
|
$25.1M |
| 4 |
Johnson & Johnson
JNJ
|
$24.8M |
| 5 |
Pfizer
PFE
|
$24.7M |
Sector Composition
| 1 | Healthcare | 98.1% |
| 2 | Industrials | 1.09% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
MeiraGTx Holdings
MGTX
$590M
| $6.93M | 0.68% |
500,000
+50,000
| +11% | +$693K |
|
|
IMGN
52
DELISTED
Immunogen Inc
IMGN
| $6.78M | 0.67% |
1,425,000
-75,000
| -5% | -$357K |
|
53
Teladoc Health
TDOC
$1.36B
| $6.64M | 0.65% |
92,000
-33,000
| -26% | -$2.38M |
|
54
Guardant Health
GH
$7.45B
| $6.29M | 0.62% |
95,000
-105,000
| -53% | -$6.96M |
|
|
SILK
55
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $6.19M | 0.61% |
150,000
-50,000
| -25% | -$2.06M |
|
56
Glaukos
GKOS
$5.18B
| $6.09M | 0.6% |
105,291
-69,709
| -40% | -$4.03M |
|
57
NovoCure
NVCR
$1.34B
| $5.78M | 0.57% |
69,700
-50,687
| -42% | -$4.2M |
|
|
AERI
58
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $5.36M | 0.53% |
589,200
-160,800
| -21% | -$1.46M |
|
59
Exact Sciences
EXAS
$9.78B
| $5.31M | 0.52% |
76,000
-34,000
| -31% | -$2.38M |
|
60
Progyny
PGNY
$2.01B
| $5.14M | 0.51% |
100,000
-1,262
| -1% | -$64.9K |
|
61
Immunocore
IMCR
$1.79B
| $5.1M | 0.5% |
170,472
+80,472
| +89% | +$2.41M |
|
62
Alkermes
ALKS
$4.79B
| $4.74M | 0.47% |
180,000
-30,000
| -14% | -$789K |
|
63
Health Catalyst
HCAT
$227M
| $4.7M | 0.46% |
180,000
-60,000
| -25% | -$1.57M |
|
64
Esperion Therapeutics
ESPR
$488M
| $4.56M | 0.45% |
981,582
-18,418
| -2% | -$85.5K |
|
65
GoodRx Holdings
GDRX
$1.45B
| $4.54M | 0.45% |
+235,000
| New | +$4.54M |
|
66
Sangamo Therapeutics
SGMO
$159M
| $4.42M | 0.44% |
761,429
-3,571
| -0.5% | -$20.7K |
|
|
ISEE
67
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $4.38M | 0.43% |
260,000
-90,000
| -26% | -$1.51M |
|
|
ONEM
68
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $4.16M | 0.41% |
375,250
-154,750
| -29% | -$1.71M |
|
|
OSH
69
DELISTED
Oak Street Health, Inc.
OSH
| $4.03M | 0.4% |
150,000
-70,000
| -32% | -$1.88M |
|
|
RVNC
70
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.87M | 0.38% |
+198,358
| New | +$3.87M |
|
71
Rigel Pharmaceuticals
RIGL
$688M
| $3.82M | 0.38% |
127,777
-24,223
| -16% | -$724K |
|
72
Intellia Therapeutics
NTLA
$1.23B
| $3.63M | 0.36% |
+50,000
| New | +$3.63M |
|
|
ACCD
73
DELISTED
Accolade, Inc. Common Stock
ACCD
| $3.51M | 0.35% |
200,000
-10,000
| -5% | -$176K |
|
|
MYOV
74
DELISTED
Myovant Sciences Ltd.
MYOV
| $3.32M | 0.33% |
249,300
-700
| -0.3% | -$9.33K |
|
75
Nektar Therapeutics
NKTR
$615M
| $3.31M | 0.33% |
40,926
-22,407
| -35% | -$1.81M |
|